Trusted News Discovery Since 2008
{{/content}}
First Phase 3 Coronavirus Vaccine Candidate Begins Testing in US
Video Credit: Wibbitz Top Stories
Published on July 28, 2020 - Duration: 01:05s
First Phase 3 Coronavirus Vaccine Candidate Begins Testing in US
First Phase 3 Coronavirus Vaccine Candidate Begins Testing in US The experimental vaccine, developed by Moderna and the National Institute of Allergy and Infectious Diseases, began Phase 3 trials on Monday.
Moderna CEO Stephane Bancel, via statement The trial will consist of about 30,000 adult volunteers who will be separated into a trial group and a control group, according to CNN.
Moderna, along with several other drug manufacturers, have received funding for vaccine research through the federal government’s Operation Warp Speed program.
The World Health Organization currently lists roughly 25 potential vaccines in clinical trials worldwide.
You are here
Related news from verified sources
Human clinical trials for Covaxin, a vaccine candidate for Covid-19 being developed by Bharat Biotech has been initiated across the country in 375 volunteers,...
on July 17, 2020 • IndiaTimes
The phase-I human clinical trial of India's first indigenously-developed vaccine against novel coronavirus, Covaxin, began at the AIIMS in New Delhi on Friday...
on July 24, 2020 • IndiaTimes
Related videos from verified sources
Moderna's Covid-19 vaccine enters Phase-3 trials| What phase-3 involves | Oneindia News 01:23
Video credit: Oneindia - Published on July 28, 2020
News Anchor Makes History By Receiving First Shot In US Phase 3 Trial Of Coronavirus Vaccine 02:07
Video credit: KCAL 9 CBS LA - Published on July 28, 2020
Proposed COVID-19 Vaccine Becomes First in U.S. to Reach Phase 3 Test Trials 00:57
Video credit: Veuer - Published on July 27, 2020